Stocks / NASDAQ / Repros Therapeutics Inc.

Repros Therapeutics Inc.

Our Opinion

Repros Therapeutics is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical research and development.

Supporting Evidence:

The company stated in the following document that they conduct pre-clinical trials of their drugs on animals.

“The Company has also completed a thorough toxicity panel in animal models that meets ICH guidelines. This includes two successfully completed carcinogenicity studies. Of particular note, in the two year rat study, animals dosed with Proellex® exhibited a lower incidence of mammary tumors than control animals.” (Page 5) Read the full document

Company Description

Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of oral small molecule drugs for unmet medical needs that treat male and female reproductive disorders. Its current product pipeline consists of Enclomiphene and Proellex. [Source: MarketWatch]

Company Website: http://www.reprosrx.com